Evaluation of Human Zinc Absorption From Wheat-based Meals
- Conditions
- Zinc Deficiency
- Interventions
- Dietary Supplement: Biofortified wheatDietary Supplement: PlaceboDietary Supplement: Fortified wheat
- Registration Number
- NCT01775319
- Lead Sponsor
- Swiss Federal Institute of Technology
- Brief Summary
Study part 1 and 2 Assessment of Zn absorption from regular and biofortified wheat: stable isotope absorption studies in women of childbearing age consuming test meals prepared from either the biofortified Zn wheat, regular wheat or post-harvest fortified wheat at two different extraction rates.
Study part 3 Assessment of Zn absorption from intrinsically and extrinsically labeled wheat: stable isotope absorption studies in women of childbearing age, or men, consuming test meals prepared from either intrinsically labeled Zn biofortified wheat, regular wheat or post-harvest fortified wheat extrinsically labeled immediately before consumption.
- Detailed Description
The overall goal of study part 1 and 2 is to evaluate and compare the fractional and absolute Zn absorption from biofortified wheat cultivar (60 ppm Zn) to regular wheat (28 ppm Zn) and to post harvest fortified wheat (60 ppm Zn) for a total of 3 test meals per study. The studies will be conducted with products based on wheat with high extraction rate (study part 1) and medium extraction rate (study part 2) in two separate groups of women of childbearing age.
The goal of study part 3 is to investigate the difference of absorption measurements between intrinsically and extrinsically labeled biofortified wheat. The label of the test meals will have the same nature as the fortificant itself (extrinsic vs intrinsic), for a total of 3 test meals.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 54
- Female, 18 to 45 years old (Study part 1 and 2). Female or male, 18 to 45 years old (Study part 3)
- Body Mass Index in the range of 18.5 to 25 kg/m2
- Signed informed consent
- Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, anemia, hepatitis, hypertension, cancer or cardiovascular diseases (according to the subjects own statement)
- Gluten intolerance, celiac disease
- Continuous/long-term use of medication during the whole study (except for contraceptives)
- Vegans
- Consumption of mineral and vitamin supplements within 2 weeks prior to 1st test meal administration
- Smoking
- Pregnancy (Urine pregnancy test shall be performed before each test meal administration)
- Lactating
- Earlier participation in a study using Zn stable isotopes or participation in any other clinical study within the last 30 days
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Biofortified wheat Biofortified wheat Biofortified wheat Control wheat Placebo Control wheat with low level of Zn Fortified wheat Fortified wheat Wheat fortified before consumption
- Primary Outcome Measures
Name Time Method Fractional zinc absorption from different wheat-based test meals 3 months Fractional zinc absorption (in %) will be assessed with stable isotopes of zinc using a double isotope technique.
- Secondary Outcome Measures
Name Time Method Zn and C-reactive protein concentration in plasma 3 months